Clinical Trial Update: Tobramycin Delivered by Nebulized Sonic Aerosol for Chronic Rhinosinusitis Treatment of Cystic Fibrosis Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tobramycin delivered via nebulized sonic aerosol for chronic rhinosinusitis in cystic fibrosis patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Rhinosinusitis

Drugs mentioned

• TOBRAMYCIN (Tobramycin)

Snippet

Sponsor: Virginie ESCABASSE | Conditions: Cystic Fibrosis, Rhinosinusitis | Phase 3 | Status: TERMINATED